PharmaCord Names Cindy Padgett As Chief Commercial Officer To Enhance Client Services

PharmaCord LLC, a prominent player in the provision of patient support services for the pharmaceutical sector, recently announced a significant addition to its leadership team. Cindy Padgett has been appointed as the Chief Commercial Officer, a role in which she will spearhead the commercialization of both corporate and client initiatives. This encompasses everything from solution design to enhancing customer experiences. Her responsibilities will extend across various departments including Solutions Development, Quality Operations, Legal Operations, and Business Optimization and Standardization.

Nitin Sahney, the Founder and CEO of PharmaCord, lauded Cindy's contributions to the team over the years. "Cindy has been an invaluable member of our team for several years, consistently demonstrating strong leadership, strategic thinking, and a relentless commitment to excellence," he remarked. Sahney expressed confidence in Padgett's abilities to elevate the company's commercial activities further.

Bringing over two decades of experience in the healthcare industry to her new role, Padgett has a commendable track record of fostering commercial success and crafting unique client experiences. Her journey with PharmaCord began in 2017, where she has since undertaken various roles, most notably serving as the company’s Vice President and General Counsel. Her career prior to joining PharmaCord includes significant positions such as Vice President of Reimbursement and Contracting for U.S. WorldMeds and Director of Fund Development at The Assistance Fund, among others. Padgett's community involvement is notable as well, with her serving on the board of Kentucky Adoption Services and participating in various capacities within Boy Scouts in La Grange, Ky.

Padgett's academic credentials include a Bachelor of Science in Business Administration and a Juris Doctor degree from the University of Louisville Louis D. Brandeis School of Law. She is licensed to practice law in the Commonwealth of Kentucky.

PharmaCord operates as a crucial intermediary between drug manufacturers and patients, aiming to streamline the prescription journey for patients. Leveraging its proprietary technology suite known as PharmaCord Lynk™, alongside a highly skilled team and its non-commercial pharmacy PharmaCord Scripts™, the company is dedicated to improving patients' access to and adherence with their vital medications. PharmaCord's efforts are instrumental in enhancing commercial outcomes for companies within the life sciences sector. For more information about PharmaCord's services and impact on patient support within the biopharmaceutical industry, visit pharmacord.com.

This strategic appointment marks a significant step for PharmaCord as it continues to expand its influence within the patient support services domain. Cindy Padgett's extensive background and proven leadership skills are expected to drive substantial advancements in how pharmaceutical companies connect with their end-users, ultimately contributing to better patient care and service delivery.